Assessment of glycaemic control and risk of hypoglycaemia for two basal-bolus algorithms in hospitalised patients with diabetes mellitus type 2

被引:0
|
作者
Mader, J. K. [1 ]
Neubauer, K. M. [1 ]
Schaupp, L. [1 ]
Aberer, F. [1 ]
Donsa, K. [2 ]
Augustin, T. [2 ]
Spat, S. [2 ]
Hoell, B. [2 ]
Beck, P. [2 ]
Plank, J. [1 ]
Pieber, T. R. [1 ]
机构
[1] Med Univ Graz, Graz, Austria
[2] Joanneum Res GmbH, HLTH, Graz, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
979
引用
收藏
页码:S402 / S402
页数:1
相关论文
共 50 条
  • [1] Assessment of Glycemic Control and Risk of Hypoglycemia for Two Basal-Bolus Algorithms in Hospitalized Patients with Diabetes Mellitus Type 2
    Mader, Julia K.
    Neubauer, Katharina M.
    Schaupp, Lukas
    Aberer, Felix
    Donsa, Klaus
    Augustin, Thomas
    Spat, Stephan
    Hoell, Bernhard
    Beck, Peter
    Plank, Johannes
    Pieber, Thomas R.
    DIABETES, 2014, 63 : A238 - A239
  • [2] Glycaemic control with insulin glulisine versus regular human insulin in a basal-bolus regimen in patients with Type 2 diabetes
    Dailey, G
    Rosenstock, J
    Moses, R
    Ways, K
    DIABETOLOGIA, 2004, 47 : A265 - A266
  • [3] Basal-bolus insulin therapy and glycemic control in adult patients with type 2 diabetes mellitus: A review of the literature
    Jackson, Bridget
    Grubbs, Laurie
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2014, 26 (06) : 348 - 352
  • [4] Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach
    Bhawna Attri
    Alpesh Goyal
    Yashdeep Gupta
    Nikhil Tandon
    Diabetes Therapy, 2020, 11 : 2177 - 2194
  • [5] Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach
    Attri, Bhawna
    Goyal, Alpesh
    Gupta, Yashdeep
    Tandon, Nikhil
    DIABETES THERAPY, 2020, 11 (09) : 2177 - 2194
  • [6] Intensification of insulin therapy in patients with type 2 diabetes mellitus: An algorithm for basal-bolus therapy
    Abrahamson, Martin J.
    Peters, Anne
    ANNALS OF MEDICINE, 2012, 44 (08) : 836 - 846
  • [7] Basal Plus Basal-Bolus Approach in Type 2 Diabetes
    Javier Ampudia-Blasco, F.
    Rossetti, Paolo
    Ascaso, Juan F.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 : S - 75
  • [8] EVALUATION OF GLYCEMIC CONTROL USING AN ALGORITHM FOR BASAL BOLUS INSULIN THERAPY IN HOSPITALISED PATIENTS WITH DIABETES MELLITUS TYPE 2
    Mader, J. K.
    Neubauer, K. M.
    Schaupp, L.
    Aberer, F.
    Augustin, T.
    Spat, S.
    Hoell, B.
    Beck, P.
    Plank, J.
    Pieber, T. R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 : A8 - A8
  • [9] Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal-Bolus Type 1): 2-year results of a randomized clinical trial
    Bode, B. W.
    Buse, J. B.
    Fisher, M.
    Garg, S. K.
    Marre, M.
    Merker, L.
    Renard, E.
    Russell-Jones, D. L.
    Hansen, C. T.
    Rana, A.
    Heller, S. R.
    DIABETIC MEDICINE, 2013, 30 (11) : 1293 - 1297
  • [10] Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe
    Mauricio, D.
    Liao, L.
    Wang, H.
    Cali, A.
    Stella, P.
    Carita, P.
    Khunti, K.
    DIABETOLOGIA, 2015, 58 : S464 - S465